Bart should be able to raise some capital now they’ve got some kind of story with this FDA ODD. How low they have to sell the shares at is another thing. I think the biggest liability going forward will be GK as major shareholder.
Ann: US FDA grants Orphan Drug Designation for CRO-67, page-43
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
